Literature DB >> 11984136

Global increases in kidney cancer incidence, 1973-1992.

A Mathew1, S S Devesa, J F Fraumeni, W-H Chow.   

Abstract

Reports of increasing rates for kidney cancers in several count prompted this analysis of global incidence trends for total kidney cancers and by subsite. International incidence data for 5-year periods 1973-1977, 1978-1982, 1983-1987 and 1988-1992 were obtained from volumes IV to VII of Cancer Incidence in Five Continents published by the International Agency for Research on Cancer. The USA data for the same 5-year periods were obtained from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Percentage changes in incidence rates were computed using the relative difference between the time periods 1973-1977 and 1988-1992, and annual percentage changes in incidence rates were computed using log linear regression. In 1988-1992, kidney cancer incidence rates (age-adjusted to the world-standard population) were highest in France (16.1/100,000 man-years and 7.3/100,000 woman-years) and lowest in India (2.0 and 0.9, respectively). Between 1973-1977 and 1988-1992, incidence rates rose among men and women in all regions and ethnic groups, with a few exceptions, mostly in Scandinavian countries. The largest percentage increase for men was in Japan (171%) and for women in Italy (107%). Rates for renal pelvis cancer were less than 1/100,000 person-years in almost all regions in both sexes, and the temporal trends were inconsistent. Incidence trends for renal parenchyma cancer tracked those for total kidney cancers, and appeared to result from increases in the prevalence of risk factors and in use of diagnostic imaging procedures.

Entities:  

Mesh:

Year:  2002        PMID: 11984136     DOI: 10.1097/00008469-200204000-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  102 in total

1.  Renal cancer paradox: higher incidence but not higher mortality among African-Americans.

Authors:  Loren Lipworth; Joseph K McLaughlin; Robert E Tarone; William J Blot
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

2.  Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies.

Authors:  S C Larsson; A Wolk
Journal:  Diabetologia       Date:  2011-01-28       Impact factor: 10.122

3.  Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population.

Authors:  Wani Arjumand; Shiekh Tanveer Ahmad; Amlesh Seth; Ashish Kumar Saini; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-09-20

Review 4.  Management of locally recurrent kidney cancer.

Authors:  Eric A Singer; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

5.  Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999-2004.

Authors:  Robin Taylor Wilson; Lisa C Richardson; Janet J Kelly; Judith Kaur; Melissa A Jim; Anne P Lanier
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

Review 6.  Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature.

Authors:  Hiten D Patel; Michael H Johnson; Phillip M Pierorazio; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-02-18       Impact factor: 7.450

7.  2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses.

Authors:  Rakesh Kumar; Anil Chauhan; Paras Lakhani; Yan Xiu; Hongming Zhuang; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

8.  Prevalence of baseline chronic kidney disease in 2,769 Chinese patients with renal cancer: nephron-sparing treatment is still underutilized.

Authors:  Kai-wei Yang; Geng-yan Xiong; Xue-song Li; Yuan Tang; Qi Tang; Cui-jian Zhang; Zhi-song He; Li-qun Zhou
Journal:  World J Urol       Date:  2014-08       Impact factor: 4.226

9.  Low C24-OH and C22-OH sulfatides in human renal cell carcinoma.

Authors:  Il Chan Kim; Geul Bang; Jeong Hwa Lee; Kwang Pyo Kim; Young Hwan Kim; Hark Kyun Kim; Jinsoo Chung
Journal:  J Mass Spectrom       Date:  2014-05       Impact factor: 1.982

10.  Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis.

Authors:  Luise Maute; Viktor Grünwald; Steffen Weikert; Ulrich Kube; Thomas Gauler; Christoph Kahl; Iris Burkholder; Lothar Bergmann
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.